Showing results (291-300 of 358) with videos related to

Sort By:
Pageof 36
NPJ Breast Cancer|September 26, 2019
PIK3CA and MAP3K1 alterations imply luminal A status and are associated with clinical benefit from pan-PI3K inhibitor buparlisib and letrozole in ER+ metastatic breast cancerMellissa J Nixon, Luigi Formisano, Ingrid A Mayer, et al.
Cancer Research|February 18, 2011
Trastuzumab has preferential activity against breast cancers driven by HER2 homodimersRitwik Ghosh, Archana Narasanna, Shizhen Emily Wang, et al.
ACS Nano|December 19, 2019
Multimodal Multiplexed Immunoimaging with Nanostars to Detect Multiple Immunomarkers and Monitor Response to ImmunotherapiesYu-Chuan Ou, Xiaona Wen, Christopher A Johnson, et al.
Nature Communications|September 21, 2017
Agonist immunotherapy restores T cell function following MEK inhibition improving efficacy in breast cancerSathana Dushyanthen, Zhi Ling Teo, Franco Caramia, et al.
Journal of Visualized Experiments : Jove|February 28, 2022
A Porcine Heterotopic Heart Transplantation Protocol for Delivery of Therapeutics to a Cardiac AllograftMichelle Mendiola Pla, Amy Evans, Franklin H Lee, et al.
Ebiomedicine|April 8, 2026
irAE-GPT: leveraging large language models to identify immune-related adverse events in electronic health records and clinical trial datasetsCosmin A Bejan, Michelle Wang, Sriram Venkateswaran, et al.
Breast Cancer Research : BCR|October 7, 2024
Clinical characterization, prognostic, and predictive values of HER2-low in patients with early breast cancer in the PALLAS trial (ABCSG-42/AFT-05/BIG-14-13/PrE0109)Guilherme Nader-Marta, Christian Singer, Dominik Hlauschek, et al.
Medrxiv : the Preprint Server for Health Sciences|March 17, 2025
irAE-GPT: Leveraging large language models to identify immune-related adverse events in electronic health records and clinical trial datasetsCosmin A Bejan, Michelle Wang, Sriram Venkateswaran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 10, 2025
The Impact of JAK1 Pathogenic Variants and MHC-I Expression on Response to Immune Checkpoint Inhibition in Endometrial CancerErica V Carballo, Paula Gonzalez-Ericsson, Brian D Lehmann, et al.
Cancer Discovery|November 4, 2011
ERα-dependent E2F transcription can mediate resistance to estrogen deprivation in human breast cancerTodd W Miller, Justin M Balko, Emily M Fox, et al.
Pageof 36